Open Access
Editorial
Issue
BioMedicine
Volume 7, Number 4, December 2017
Article Number 21
Number of page(s) 3
DOI https://doi.org/10.1051/bmdcn/2017070421
Published online 13 November 2017
  1. Riss J, Khanna C, Koo S, Chandramouli GV, Yang HH, Hu Y, et al. Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Res 2006; 66: 7216-24. [CrossRef] [Google Scholar]
  2. Cancer Research UK. Worldwide Cancer Statistics. 2016. http://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer#heading-Zero Accessed 18/09/2016. [Google Scholar]
  3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. [CrossRef] [PubMed] [Google Scholar]
  4. Callahan, C,Brintzenhofeszoc K. Financial Quality of Life for Patients With Cancer: An Exploratory Study. J Psychosoc Oncol. 2015, 33: 377-94. [CrossRef] [Google Scholar]
  5. Heydarnejad MS, Hassanpour DA, Solati DK. Factors affecting quality of life in cancer patients undergoing chemotherapy. Afr Health Sci. 2011, 11: 266-70. [PubMed] [Google Scholar]
  6. Khan, N, Mukhtar H. Cancer and metastasis: prevention and treatment by green tea. Cancer Metastasis Rev. 2010, 29: 435-45. [CrossRef] [PubMed] [Google Scholar]
  7. Chiang AC, Massagué J. Molecular Basis of Metastasis. N Engl J Med. 2008, 359: 2814-23. [CrossRef] [PubMed] [Google Scholar]
  8. Steeg PS. Targeting metastasis. Nature Reviews Cancer. 2016, 16:201-201. [CrossRef] [PubMed] [Google Scholar]
  9. Lou XL, Sun J, Gong SQ, Yu XF, Gong R, Deng H. Interaction between circulating cancer cells and platelets: clinical implication. Chin J Cancer Res. 2015, 27: 450-60. [PubMed] [Google Scholar]
  10. Varki, A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood. 2007, 110: 1723-9. [CrossRef] [PubMed] [Google Scholar]
  11. Sharma, D,Brummel-Ziedins KE, Bouchard BA, Holmes CE. Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer. J Cell Physiol. 2014, 229: 1005-15. [CrossRef] [PubMed] [Google Scholar]
  12. Li, N. Platelets in cancer metastasis: To help the “villain” to do evil. Int J Cancer. 2016, 138: 2078-87. [CrossRef] [PubMed] [Google Scholar]
  13. Labelle, M,Begum S, Hynes RO. Platelets guide the formation of early metastatic niches. Proc Natl Acad Sci U S A. 2014, 111: E3053-61. [CrossRef] [PubMed] [Google Scholar]
  14. Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest. 2009, 135: 505-12. [CrossRef] [PubMed] [Google Scholar]
  15. Rachagani, S,Torres MP, Moniaux N, Batra SK. Current status of mucins in the diagnosis and therapy of cancer. Biofactors. 2009, 35: 509-27. [CrossRef] [PubMed] [Google Scholar]
  16. Wang RQ, Fang DC. Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features. J Clin Pathol. 2003, 56: 378-84. [CrossRef] [PubMed] [Google Scholar]
  17. Duncan TJ, Watson NF, Al-Attar AH, Scholefield JH, Durrant LG. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer. World J Surg Oncol. 2007, 5: 31. [CrossRef] [PubMed] [Google Scholar]
  18. Choi JS, Lee KMA, Lee HE, Lee HS, Kim WH. Mucinous gastric carcinomas. Cancer. 2009, 115: 3581-90. [CrossRef] [PubMed] [Google Scholar]
  19. Borsig, L,Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A. 2001, 98: 3352-7. [CrossRef] [PubMed] [Google Scholar]
  20. Varki, A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood. 2007, 110: 1723-9. [CrossRef] [PubMed] [Google Scholar]
  21. Fukuda, M. Possible roles of tumor-associated carbohydrate antigens. Cancer Res. 1996; 56: 2237-44. [Google Scholar]
  22. Varki, N.M., Varki, A. Semin. Thromb. Hemostasis, in press. 2002. [Google Scholar]
  23. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 1996, 88: 3259-87. [Google Scholar]
  24. Varki, A. Selectin ligands. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:7390-7390. [CrossRef] [PubMed] [Google Scholar]
  25. Evangelista, V,Manarini S, Sideri R, Rotondo S, Martelli N, Piccoli A. et al. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood. 1999, 93:876-876. [Google Scholar]
  26. Hidari KI, Weyrich AS, Zimmerman GA, McEver RP. Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils. J. Biol. Chem. 1997; 272: 28750-6. [CrossRef] [PubMed] [Google Scholar]
  27. Merten, M, Thiagarajan P. Role for sulfatides in platelet aggregation. Circulation. 2001, 104: 2955-60. [CrossRef] [PubMed] [Google Scholar]
  28. Kim YJ, Borsig L, Varki NM, Varki A. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci U S A. 1998,95: 9325-30. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.